The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Morgan Stanley maintains Buy rating on Genscript Biotech, sets HK$88 target

Oct 31, 2026 03:25 (10h ago)

Verifying

Morgan Stanley maintained a Buy rating and set an HK$88.00 target for Genscript Biotech.
Genscript Biotech shares closed last Wednesday at HK$37.70.
Genscript Biotech has a Strong Buy consensus and an HK$43.70 consensus target.